Medical Engineered Materials Market Report 2026

Medical Engineered Materials Market Overview

• Medical Engineered Materials market size has reached to $25.24 billion in 2025 • Expected to grow to $48.85 billion in 2030 at a compound annual growth rate (CAGR) of 13.9% • Growth Driver: Rise In Surgical Procedures To Drive Market Growth • Market Trend: Advanced Material Solution Elevates Durability Standards In Healthcare And Life Sciences Sector • Asia-Pacific was the largest region and fastest growing region.

What Is Covered Under Medical Engineered Materials Market?

Medical engineered materials refer to a material that is engineered to specific or custom requirements to engage with biological systems in a therapeutic or diagnostic manner for medical purposes. It is generally a link between science, technology, and medicine and is also known as biomaterials. The medical engineered materials are used to integrate key materials science modules with an understanding of medical design. The main types of medical engineered materials are medical plastics, medical foams, medical films, medical adhesives, and medical elastomers. Medical-grade plastic materials refer to plastics designed to make medical products. It is used for manufacturing products for in vitro diagnostics and primary packaging for pharmaceuticals, which preserves and contains medicines to avoid contamination. The various applications involved medical devices, medical disposables, medical wearables, and advanced wound care.

What Is The Medical Engineered Materials Market Growth Forecast?

The medical engineered materials market size is expected to see rapid growth in the next few years. It will grow to $48.85 billion in 2030 at a compound annual growth rate (CAGR) of 13.9%. The growth in the forecast period can be attributed to increasing demand for next-generation implants, rising focus on regenerative medicine, expansion of personalized medical devices, growing use of sustainable medical materials, advancements in material engineering technologies. Major trends in the forecast period include increasing development of advanced biomaterials, rising use of customized medical polymers, growing demand for biocompatible and bioresorbable materials, expansion of engineered materials for implants, enhanced focus on material performance and safety.

What Is The Driver Of The Medical Engineered Materials Market?

The rising number of surgical procedures is expected to propel the growth of medical engineered materials market going forward. Surgical procedures refer to medical interventions or treatments that involve making incisions or using invasive techniques to access and treat internal or external areas of the body. Rise in surgical procedures leads to increased demand for materials used in surgical instruments, implantable devices, and minimally invasive procedures. Biocompatible and infection-resistant materials are essential for ensuring patient safety. Customization and regulatory standards drive research and development, while cost efficiency and technological advancements lead to material innovation. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, minimally invasive procedures increased by 7% in 2023, outpacing the growth rate of surgical procedures by 2%. Hand surgeries such as carpal tunnel, arthritis, and trigger finger totaled 207,887 procedures, a 2% rise from 2022. Therefore, the rising number of surgical procedures is driving the growth of medical engineered materials industry.

Key Players In The Global Medical Engineered Materials Market

Major companies operating in the medical engineered materials market are Evonik Industries AG, Covestro AG, BASF SE, Solvay SA, Saudi Basic Industries Corporation, Trelleborg AB, Koninklijke DSM N.V., Celanese Corporation, DuPont de Nemours Inc., Henkel AG & Co. KGaA, Huntsman Corporation, Momentive Performance Materials Inc., Nitto Denko Corporation, Recticel Ltd., Victrex plc, Ensinger GmbH, RTP Company, Foster Corporation, Zeus Industrial Products Inc., Saint-Gobain SA, Arkema SA, Eastman Chemical Company, Lubrizol Corporation, PolyOne Corporation, Quadrant AG, Röchling Group, DSM Biomedical, Invibio Ltd., Carpenter Technology Corporation, Heraeus Medical Components GmbH, CeramTec GmbH, Morgan Advanced Materials plc, Freudenberg Medical LLC

Global Medical Engineered Materials Market Trends and Insights

Major companies operating in the medical engineered materials market are focusing on developing advanced material solutions such as high-durability materials to enhance safety, performance, and sterilization compatibility in healthcare applications. High-durability materials are engineered to withstand extreme conditions, mechanical stress, and chemical exposure without degrading, helping ensure long-lasting performance, safety, and repeated sterilization in medical applications. For instance, in February 2023, Covestro AG, a Germany-based polymer materials company launched Makrolon 3638 polycarbonate, an advanced material solution tailored for healthcare and life sciences applications. It offers high durability across a wide temperature range, from cryogenic to steam sterilization conditions, along with high impact strength and ductility. The material boasts high chemical resistance, meets medical-grade and biocompatibility standards, and is suitable for skin contact applications. Additionally, it is food contact quality and can be sterilized using common methods in the healthcare sector.

What Are Latest Mergers And Acquisitions In The Medical Engineered Materials Market?

In June 2023, STRATEC SE, a Germany-based healthcare technology company, acquired Natech Plastics, Inc. for an undisclosed amount. With this acquisition, STRATEC aimed to strengthen its presence in the U.S. market, diversify its customer base, and leverage synergies in consumable technology. Natech Plastics is a US-based manufacturing company that specializes in designing and manufacturing smart polymer-based consumables for medical technology, in-vitro diagnostics, life sciences, consumer goods, and specialist packaging.

What Defines the Medical Engineered Materials Market?

The medical engineered materials market consists of sales of medical plastics, medical foams, medical films, medical elastomers, and medical adhesives. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Medical Engineered Materials Market Report 2026?

The medical engineered materials market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the medical engineered materials industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.